Syndax Pharmaceuticals Stock Options
| SNDX Stock | USD 19.30 0.03 0.16% |
Syndax Pharmaceuticals' latest option contracts expiring on 2024-06-21 are carrying combined implied volatility of 42.81 with a put-to-call open interest ratio of 1.91 over 22 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on 2024-06-21. The current put volume is at 50, with calls trading at the volume of 0. This yields a 0.0 put-to-call volume ratio.
Open Interest Against 2024-06-21 Option Contracts
Syndax Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Syndax Pharmaceuticals' lending market. For example, when Syndax Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Syndax Pharmaceuticals, he or she must hedge the risk by shorting Syndax Pharmaceuticals stock over its option's life.
2024-06-21
The chart above shows Syndax Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Syndax Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Syndax Pharmaceuticals' option, there is no secondary market available for investors to trade.
Syndax Pharmaceuticals' option chain provides insight into all available option contracts written on Syndax Pharmaceuticals' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Syndax Pharmaceuticals' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Syndax option contract.
In The Money vs. Out of Money Option Contracts on Syndax Pharmaceuticals
Analyzing Syndax Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Syndax Pharmaceuticals regardless of its overall volatility. This is especially true when Syndax Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Syndax Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Syndax Pharmaceuticals' stock while costing only a fraction of its price.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Syndax Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Syndax Current Options Market Mood
Syndax Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Syndax Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Syndax Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Syndax Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Syndax Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Syndax contract
Base on the Rule 16, the options market is currently suggesting that Syndax Pharmaceuticals will have an average daily up or down price movement of about 2.68% per day over the life of the 2024-06-21 option contract. With Syndax Pharmaceuticals trading at USD 19.3, that is roughly USD 0.52. If you think that the market is fully incorporating Syndax Pharmaceuticals' daily price movement you should consider buying Syndax Pharmaceuticals options at the current volatility level of 42.81%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Syndax |
Purchasing Syndax Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Syndax calls. Remember, the seller must deliver Syndax Pharmaceuticals stock to the call owner when a call is exercised.
Syndax Pharmaceuticals Option Chain
When Syndax Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Syndax Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Syndax Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Syndax. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Syndax. It also shows strike prices and maturity days for a Syndax Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-06-21 CALL at $5.0 | 0.9633 | 0.0038 | 0 | 2024-06-21 | 12.8 - 16.8 | 0.0 | In |
Call | 2024-06-21 CALL at $7.5 | 0.9298 | 0.0074 | 0 | 2024-06-21 | 11.2 - 14.2 | 0.0 | In |
Call | 2024-06-21 CALL at $10.0 | 0.9117 | 0.013 | 0 | 2024-06-21 | 8.2 - 11.8 | 0.0 | In |
Call | 2024-06-21 CALL at $12.5 | 0.8625 | 0.0216 | 0 | 2024-06-21 | 6.1 - 9.4 | 0.0 | In |
Call | 2024-06-21 CALL at $15.0 | 0.7989 | 0.0365 | 5 | 2024-06-21 | 3.9 - 6.9 | 6.0 | In |
Call | 2024-06-21 CALL at $17.5 | 0.7019 | 0.0727 | 0 | 2024-06-21 | 1.75 - 4.0 | 0.0 | In |
Put | 2024-06-21 PUT at $20.0 | -0.6269 | 0.2143 | 342 | 2024-06-21 | 0.0 - 3.4 | 1.1 | In |
Put | 2024-06-21 PUT at $22.5 | -0.8448 | 0.0887 | 21 | 2024-06-21 | 2.75 - 4.0 | 2.68 | In |
Put | 2024-06-21 PUT at $25.0 | -0.7238 | 0.0515 | 0 | 2024-06-21 | 3.2 - 6.6 | 0.0 | In |
Put | 2024-06-21 PUT at $30.0 | -0.9039 | 0.0293 | 0 | 2024-06-21 | 9.2 - 12.6 | 0.0 | In |
Put | 2024-06-21 PUT at $35.0 | -0.7951 | 0.0272 | 0 | 2024-06-21 | 14.7 - 16.6 | 0.0 | In |
Syndax Pharmaceuticals Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Syndax Pharmaceuticals Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Syndax Total Stockholder Equity
Total Stockholder Equity |
|
Syndax Pharmaceuticals Corporate Management
| Briggs MD | Head Pres | Profile | |
| Steven Closter | Chief Officer | Profile | |
| Michael MBA | CEO Director | Profile | |
| Steve Sabus | Chief Officer | Profile | |
| Joseph MD | Member Officer | Profile | |
| Ronald Evans | Advisor CoFounder | Profile | |
| Sharon Klahre | Vice Communications | Profile |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.